Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Journal of Comprehensive Pediatrics

homeHome
check_circleAccepted Manuscriptsplay_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteespublicIndexing and Listing SourcesbalancePublication Ethics and Publication Malpractice StatementemailSupportshow_chartJournal Metricsassignment_indReviewer and AE Registration FormphoneContact Uszoom_inOpen Peer Review (OPR)
view_listAPC
Authors GuideSubmit Manuscript

Crossref

1. Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis

- Shehab Yaser

- Hatem Yaser

- Hazem E. Mohammed

- Mohamed Nasser

- Mohamed Khalafalla Darwish

- Mohamed E. Haseeb

- Anas Hussein Heiba

- Mohamed Mabrouk Ghonaim

- Heba Aboeldahab

- Zeyad Bady

2. Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes

- Razieh Parizad

- Juniali Hatwal

- Ajit Singh Brar

- Leila Alizadeh

- Manjeet Kumar Goyal

- Akash Batta

- Bishav Mohan

3. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

- Nikolaos Gkiourtzis

- Panagiota Michou

- Maria Moutafi

- Agni Glava

- Konstantinos Cheirakis

- Aristeidis Christakopoulos

- Eleni Vouksinou

- Maria Fotoulaki

4. The Role of Metformin in Modifying Ferroptosis to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: A Narrative Review

- Mohammadjavad Sotoudeheian

- Reza Azarbad

- Seyed-Mohamad-Sadegh Mirahmadi

- Navid Farahmandian

5. PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis

- Zhuo-Ya Zhang

- Qi Yan

- Wen-Hao Wu

- Yuan Zhao

- Hua Zhang

- Jin Li

6. Effects of metformin on anthropometric indices and hormones and adipocytokine concentrations in children with overweight or obesity: a systematic review and meta-analysis of randomised controlled trials

- Xenophon Theodoridis

- Androniki Papaemmanouil

- Niki Papageorgiou

- Lydia Chrysoula

- Stella Stabouli

- Michail Chourdakis